• Everolimus (RAD001) Assay Reliability Guide

  2026-09-03

  Learn how Everolimus (RAD001), SKU A8169, can improve interpretation of mTOR-focused viability, proliferation, and cytotoxicity experiments. This scenario-based guide connects solvent handling, endpoint selection, dose interpretation, and supplier-quality checks with evidence from cancer assay methodology.

• Ertugliflozin (PF-04971729) Research Workflows

  2026-09-03

  Build cleaner renal glucose transport and diabetes mellitus research experiments with a highly selective SGLT2 probe. This guide connects cell-based transport assays, metabolic studies, and preclinical intestinal repair models to practical dosing, formulation, and troubleshooting decisions.

• Anagliptin Vasorelaxation: Kv Channels and SERCA

  2026-09-02

  A 2025 Acta Diabetologica study shows that Anagliptin relaxes phenylephrine-contracted rabbit aortic rings through pharmacologically sensitive voltage-dependent K+ channels and the SERCA pump. The response was independent of endothelium, cyclic-nucleotide signaling, and several other vascular K+ channel classes, providing a focused framework for vascular pharmacology and diabetes–cardiovascular research.

• Disodium Bicinchoninate for Endothelial Assays

  2026-09-02

  Disodium bicinchoninate provides an aqueous route for developing bicinchoninate-based protein measurements alongside oxidative-stress and endothelial-cell workflows. Its water solubility, defined molecular weight, and low-organic-solvent handling can improve assay preparation, while careful matrix controls help prevent misleading normalization data.

• Trelagliptin Succinate: Designing Better Assays

  2026-09-01

  Trelagliptin succinate, also known as SYR-472 succinate, connects selective DPP-4 enzyme inhibition with metabolic, inflammatory, and neural endpoints. This evidence-centered guide explains how to design assays that distinguish direct incretin effects from downstream tissue protection in diabetes mellitus research.

• Bradykinin B2 Antagonism in Synovial Fibroblasts

  2026-09-01

  This study defines bradykinin B2 receptor signaling in human synovial fibroblasts and identifies MEN16132 as a potent antagonist of receptor-driven inflammatory responses. Its combination of receptor binding, second-messenger analysis, cytokine measurements, and pathway inhibition provides a useful framework for evaluating kinin-mediated synovitis in osteoarthritis.

• Propidium iodide in Placental Immune Assays

  2026-08-31

  Use Propidium iodide to add a direct membrane-integrity endpoint to placenta-derived exosome and Jurkat T-cell experiments. The workflow complements metabolic, molecular, and Annexin V measurements by clarifying whether altered proliferation or apoptosis is accompanied by loss of viability or late-stage membrane damage.

• Carbapenemase Gene Transmission in CREC

  2026-08-30

  A 2025 BMC Microbiology study mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its combination of gene localization, conjugation, mobile-element analysis, and ERIC-PCR genotyping clarifies how blaNDM-1-associated resistance may disseminate across clinical settings.

• Entecavir BA1816 for Reliable HBV Assays

  2026-08-29

  Learn how Entecavir (BMS200475), SKU BA1816, can improve the interpretability of HBV replication, viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects nanomolar antiviral potency with practical stock preparation, vehicle control, assay interpretation, and evidence-based product selection.

• NAT10–ac4C Regulation of Mouse Oocyte Maturation

  2026-08-29

  This study identifies NAT10-mediated N4-acetylcytidine (ac4C) as a post-transcriptional regulator of mouse oocyte maturation in vitro. NAT10 knockdown reduced ac4C and impaired first polar body extrusion, while RNA-interaction analyses nominated TBL3 as a potential ac4C-associated protein.

• Fluorescein Tyramide: Reliable Signal Amplification

  2026-08-28

  This scenario-based guide explains how Fluorescein Tyramide, SKU K1084, can improve detection of low-abundance targets in immunohistochemistry, in situ hybridization, and exploratory flow workflows. It also separates signal amplification from direct viability measurement and provides practical guidance on controls, reconstitution, storage, interpretation, and vendor selection.

• Podophyllotoxin Workflows for Cell-Cycle Research

  2026-08-28

  Build reproducible cell-cycle, apoptosis, autophagy, and multidrug-resistance assays around a defined microtubule-targeting workflow. The approach connects practical compound handling with new evidence from a podophyllotoxin derivative study, while keeping parent-compound findings and derivative-specific mechanisms analytically separate.

• NLRP3 Astrocyte Remodeling in Morphine Tolerance

  2026-08-27

  Yuan et al. connect spinal NLRP3 inflammasome activation with a shift toward the A1 reactive astrocyte phenotype during morphine tolerance. Using MCC950 alongside behavioral, molecular, and imaging readouts, the study identifies inflammasome inhibition as a mechanistically informative way to test neuroinflammatory contributions to opioid tolerance.

• FLT3–TAZ Signaling in Drug-Resistant BP-CML

  2026-08-27

  Shin et al. repositioned FLT3 from an AML-associated kinase to a prognostic marker and therapeutic target in blast phase chronic myeloid leukemia (BP-CML). Their data connect FLT3 to a JAK–STAT3–TAZ–TEAD–CD36 resistance axis and support combining FLT3-directed strategies with BCR::ABL1 inhibition to address kinase-independent drug resistance.

• Enzalutamide-Induced Senescence in Prostate Cancer

  2026-08-26

  The reference study shows that DNA damage and Enzalutamide induce distinct senescence phenotypes in prostate cancer cells. Stable, DNA damage-associated senescence increased sensitivity to Bcl-xL-directed senolysis, whereas the reversible Enzalutamide response did not, demonstrating why senescence markers must be interpreted in treatment context.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page